Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | BDKRB2 | P30411 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
| ▸ | HTR2B | P41595 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | MME | P08473 | 2/20 | 0.32 |
| ▸ | ACE | P12821 | 1/20 | 0.32 |
| ▸ | CPA1 | P15085 | 1/20 | 0.32 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.32 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.32 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | MC5R | P33032 | 1/20 | 0.32 |
| ▸ | MTNR1A | P48039 | 3/20 | 0.31 |
| ▸ | BCHE | P06276 | 1/20 | 0.31 |
| ▸ | CNR2 | P34972 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3723664 | 1.00 | CYP1A2 (0.42) | CYP1A2CYP2A6BDKRB2HTR2AHTR2C | |
| SCHEMBL6656942 | 0.90 | ALDH1A1 (0.37) | BDKRB2CA2ALDH1A1CYP3A4MME | |
| SCHEMBL29023631 | 0.88 | ALDH1A1 (0.38) | BDKRB2CA2ALDH1A1CYP3A4MME | |
| SCHEMBL6656944 | 0.80 | BDKRB2 (0.47) | CYP1A2CYP2A6BDKRB2HTR2AHTR2C | |
| SCHEMBL15301082 | 0.80 | BDKRB2 (0.47) | CYP1A2CYP2A6BDKRB2HTR2AHTR2C | |
| SCHEMBL6889822 | 0.78 | CYP1A2 (0.58) | CYP1A2CYP2A6HTR2AHTR2CHTR2B | |
| SCHEMBL3731371 | 0.78 | BDKRB2 (0.51) | CYP1A2CYP2A6BDKRB2HTR2AHTR2C | |
| SCHEMBL3723663 | 0.78 | BDKRB2 (0.51) | CYP1A2CYP2A6BDKRB2HTR2AHTR2C | |
| SCHEMBL28992702 | 0.78 | MAPT (0.37) | CYP1A2BDKRB2ALDH1A1CYP3A4MAPK1 | |
| SCHEMBL14889155 | 0.78 | MAPT (0.37) | CYP1A2BDKRB2ALDH1A1CYP3A4MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070141747-A1 | Electronic device fabrication process | XEROX CORPORATION | 2007-06-21 | — | — | US | claimed |
| EP-1433211-B1 | SUBSTITUTED PENTACENE SEMICONDUCTORS | 3M INNOVATIVE PROPERTIES CO (US) | 2006-06-21 | — | — | EP | claimed |
| US-6864396-B2 | Comprise at least one substituent selected from electron-donating substituents, halogen substituents, and combinations thereof; organic thin-film transistors | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2005-03-08 | — | — | US | claimed |
| EP-1433211-A2 | SUBSTITUTED PENTACENE SEMICONDUCTORS | 3M Innovative Properties Company (US) | 2004-06-30 | — | — | EP | claimed |
| US-20030105365-A1 | Comprise at least one substituent selected from electron-donating substituents, halogen substituents, and combinations thereof; organic thin-film transistors | 3M INNOVATIVE PROPERTIES COMPANY | 2003-06-05 | — | — | US | claimed |
| WO-2003028125-A2 | SUBSTITUTED PENTACENE SEMICONDUCTORS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2003-04-03 | — | — | WO | claimed |
| US-7651885-B2 | Electronic device fabrication process | XEROX CORPORATION (US) | 2010-01-26 | — | — | US | disclosed |
| US-20070141747-A1 | Electronic device fabrication process | XEROX CORPORATION | 2007-06-21 | — | — | US | disclosed |
| EP-1433211-B1 | SUBSTITUTED PENTACENE SEMICONDUCTORS | 3M INNOVATIVE PROPERTIES CO (US) | 2006-06-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030105365-A1 | Comprise at least one substituent selected from electron-donating substituents, halogen substituents, and combinations thereof; organic thin-film transistors | ETV1, HTR3C, SLC43A1 | CYP1A2 270/4885CYP2A6 1447/4885BDKRB2 4037/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.